🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The ARTEMIS-IPF study was conducted to determine if ambrisentan was effecti...
Status
Terminated
Location
University of Alabama at Birmingham Hospital
Start Date
2008-12
Trial ID
NCT00768300
Treatments Being Tested
It is hypothesised that ambrisentan may provide benefit to subjects with in...
Status
Terminated
Location
GSK Investigational Site
Start Date
2013-09
Trial ID
NCT01884675
Treatments Being Tested
Pulmonary arterial hypertension (PAH) is a rare, progressive disease associ...
Status
Recruiting
Location
Hôpital Bicêtre -Service de pneumologie et soins intensifs respiratoires
Start Date
2026-04-28
Trial ID
NCT07245680
Treatments Being Tested
This is a multicenter, randomized (2:1 oral treprostinil: placebo), double-...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT02999906
Treatments Being Tested
Ambrisentan is an endothelin receptor antagonist used for the treatment of ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2009-07
Trial ID
NCT00879229
Treatments Being Tested
The purpose of this study is to demonstrate superiority of macitentan 75 mi...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2020-06-30
Trial ID
NCT04273945
Treatments Being Tested
This study is being conducted to determine the effectiveness of using two F...
Status
Completed
Location
Montana Center for Work Physiology and Exercise Metabolism
Start Date
2013-08
Trial ID
NCT01902758
Treatments Being Tested
To evaluate the change from baseline in pulmonary vascular resistance (PVR)...
Status
Completed
Location
University of South Alabama
Start Date
2008-04
Trial ID
NCT00617305
Treatments Being Tested